Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 3 - Number 4

Preface [Hot topic: Diabetes (Guest Editor: Alex M. DePaoli)]

, 3(4): i

Alex M. DePaoli


DOI: 10.2174/1568005033481088




Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine

, 3(4): 243 - 253

Toshimasa Yamauchi, Kazuo Hara, Naoto Kubota, Yasuo Terauchi, Kazuyuki Tobe, Philippe Froguel, Ryozo Nagai and Takashi Kadowaki


DOI: 10.2174/1568005310303040243




Tissue-Specific Glucocorticoid Reactivating Enzyme, 11β-Hydroxysteoid Dehydrogenase Type 1 (11β-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome

, 3(4): 255 - 262

Hiroaki Masuzaki and Jeffrey S. Flier


DOI: 10.2174/1568005310303040255




DGAT: Novel Therapeutic Target for Obesity and Type 2 Diabetes Mellitus

, 3(4): 263 - 270

Angela Subauste and Charles F. Burant


DOI: 10.2174/1568005310303040263




Stearoyl-CoA Desaturase-1 and the Metabolic Syndrome

, 3(4): 271 - 280

Paul Cohen, James M. Ntambi and Jeffrey M. Friedman


DOI: 10.2174/1568005310303040271




Physiological Roles of Glycogen Synthase Kinase-3: Potential as a Therapeutic Target for Diabetes and Other Disorders

, 3(4): 281 - 290

J. R. Woodgett


DOI: 10.2174/1568005310303040281




SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus

, 3(4): 291 - 298

James W. Baumgartener


DOI: 10.2174/1568005310303040291




Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity

, 3(4): 299 - 304

Shrikrishna Dadke and Jonathan Chernoff


DOI: 10.2174/1568005310303040299




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science